Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2025-12-31 @ 10:06 AM
Study NCT ID:
NCT01468792
Status:
COMPLETED
Last Update Posted:
2014-02-19
First Post:
2011-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hemodynamic Changes in Connective Tissue Disease
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012595', 'term': 'Scleroderma, Systemic'}, {'id': 'D000081029', 'term': 'Pulmonary Arterial Hypertension'}], 'ancestors': [{'id': 'D003240', 'term': 'Connective Tissue Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D006976', 'term': 'Hypertension, Pulmonary'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 85}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2014-02', 'completionDateStruct': {'date': '2014-02', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2014-02-18', 'studyFirstSubmitDate': '2011-11-07', 'studyFirstSubmitQcDate': '2011-11-07', 'lastUpdatePostDateStruct': {'date': '2014-02-19', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2011-11-09', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2014-02', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'systolic pulmonary pressure at 50 W', 'timeFrame': '3-5 years', 'description': 'change of systolic pulmonary arterial pressure after 3-5 years'}], 'secondaryOutcomes': [{'measure': 'peak (oxygen uptake) VO2', 'timeFrame': '3-5 years', 'description': 'change of peak VO2 after 3-5 years'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['systemic sclerosis', 'pulmonary arterial hypertension'], 'conditions': ['Systemic Sclerosis']}, 'referencesModule': {'references': [{'pmid': '28705939', 'type': 'DERIVED', 'citation': 'Kovacs G, Avian A, Wutte N, Hafner F, Moazedi-Furst F, Kielhauser S, Aberer E, Brodmann M, Graninger W, Foris V, Olschewski A, Olschewski H. Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study. Eur Respir J. 2017 Jul 13;50(1):1601708. doi: 10.1183/13993003.01708-2016. Print 2017 Jul.'}]}, 'descriptionModule': {'briefSummary': 'The study serves the identification of early forms of pulmonary arterial hypertension (PAH) in connective tissue disease and the hemodynamic follow-up of the investigated patients. The basic hypothesis is that PAH may start with a remodeling of small pulmonary arteries, which leads to a stiffening of the vessels, indicated by the inability to vasodilatation and thus a disproportional increase in pulmonary pressure during exercise. Recent studies have shown that a proportion of such patients may develop manifest PAH within a few years. The early identification of these patients and the understanding of the natural course of the disease may improve prognosis. The aim of the present study is to investigate hemodynamic and clinical changes in patients with connective tissue disease in a time interval of 3-5 years with a focus on the development of pulmonary hypertension.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'patients with known systemic sclerosis and without known pulmonary hypertension', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Informed consent\n* Patients with systemic sclerosis, mixed connective tissue disease, (systemic lupus erythematodes) SLE or overlap syndrome\n* Existing exercise Doppler echocardiography or/and right heart catheterization 3-5 years before inclusion\n\nExclusion Criteria:\n\n* \\- Severe lung or bronchial disease (FEV1 \\<60%)\n* Systolic LV dysfunction (LVEF \\<50%) or diastolic dysfunction \\> grade I\n* Valvular defect \\> grade I (except for tricuspid- or pulmonary insufficiency)\n* Uncontrolled systemic arterial hypertension (at rest \\>150 mmHg systolic or 95 mmHg diastolic)\n* Uncontrolled ventricular arrhythmias\n* Uncontrolled bradycardia or tachycardia supraventricular arrhythmias\n* Myocardial infarction within the last 12 months\n* Pulmonary embolism within the last 12 months\n* Relevant changes in hemodynamic therapy or major surgery within the last 12 weeks\n* Musculoskeletal or peripheral vessel disorders which complicates an ergometry'}, 'identificationModule': {'nctId': 'NCT01468792', 'briefTitle': 'Hemodynamic Changes in Connective Tissue Disease', 'organization': {'class': 'OTHER', 'fullName': 'Medical University of Graz'}, 'officialTitle': 'Hemodynamic Changes in Connective Tissue Disease', 'orgStudyIdInfo': {'id': '23-409 ex 10/11'}, 'secondaryIdInfos': [{'id': '23-409 ex 10/11', 'type': 'OTHER_GRANT', 'domain': 'MUG'}]}, 'contactsLocationsModule': {'locations': [{'zip': '8036', 'city': 'Graz', 'country': 'Austria', 'facility': 'Medical University of Graz / Pulmonology', 'geoPoint': {'lat': 47.06733, 'lon': 15.44197}}], 'overallOfficials': [{'name': 'Horst Olschewski, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Medical University of Graz'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Medical University of Graz', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}